“Incremental Risk of Adverse Events With Oral Janus Kinase Inhibitor Use in Atopic Dermatitis and Other Indications: A Systematic Review and Meta-Analysis”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s320. https://doi.org/10.25251/skin.8.supp.320.